PlainRecalls
FDA Drug Moderate Class II Terminated

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3

Reported: January 3, 2024 Initiated: November 22, 2023 #D-0203-2024

Product Description

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3

Reason for Recall

Presence of Particulate Matter.

Details

Recalling Firm
AnazaoHealth Corporation
Units Affected
5,707 vials
Distribution
Nationwide in the USA.
Location
Las Vegas, NV

Frequently Asked Questions

What product was recalled?
B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3. Recalled by AnazaoHealth Corporation. Units affected: 5,707 vials.
Why was this product recalled?
Presence of Particulate Matter.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 3, 2024. Severity: Moderate. Recall number: D-0203-2024.